Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-021377

Options or other derivatives

  • President and CEO acquired 1,156,913 shares (grant or award)
  • President and CEO returned 1,156,913 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table II: Derivative

6 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-08-17 Grant or award : show line 1 in the form Stock Option +714,413 $2.14 2029-10-01 714,413 714,413 D
2022-08-17 Returned to the company : show line 2 in the form Stock Option −714,413 $14.00 2029-10-01 714,413 0 D
2022-08-17 Grant or award : show line 3 in the form Stock Option +242,500 $2.14 2030-02-11 242,500 242,500 D
2022-08-17 Returned to the company : show line 4 in the form Stock Option −242,500 $25.05 2030-02-11 242,500 0 D
2022-08-17 Grant or award : show line 5 in the form Stock Option +200,000 $2.14 2031-01-14 200,000 200,000 D
2022-08-17 Returned to the company : show line 6 in the form Stock Option −200,000 $35.85 2031-01-14 200,000 0 D
Loading xslF345X03/form4.xml…